461 related articles for article (PubMed ID: 25558821)
1. Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment.
Lai WL; Yeh TH; Chen PM; Chan CK; Chiang WC; Chen YM; Wu KD; Tsai TJ
J Formos Med Assoc; 2015 Feb; 114(2):102-11. PubMed ID: 25558821
[TBL] [Abstract][Full Text] [Related]
2. Recent advances and prognosis in idiopathic membranous nephropathy.
Segal PE; Choi MJ
Adv Chronic Kidney Dis; 2012 Mar; 19(2):114-9. PubMed ID: 22449349
[TBL] [Abstract][Full Text] [Related]
3. [Membranous glomerulonephritis: better therapy with autoantibody monitoring?].
Stahl RA; Hoxha E; Helmchen U
Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1733-7. PubMed ID: 21877306
[TBL] [Abstract][Full Text] [Related]
4. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
Hoxha E; Harendza S; Pinnschmidt H; Panzer U; Stahl RA
PLoS One; 2014; 9(10):e110681. PubMed ID: 25313791
[TBL] [Abstract][Full Text] [Related]
5. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
6. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
7. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
10. [Membranous nephropathy: Diagnosis, new insights in pathophysiology, and therapeutic approach].
Dahan K
Rev Med Interne; 2016 Oct; 37(10):674-679. PubMed ID: 27236434
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy.
Kalantari S; Nafar M
Biomark Med; 2017 Sep; 11(9):781-797. PubMed ID: 28891307
[TBL] [Abstract][Full Text] [Related]
13. [Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B; Lambeau G; Esnault V
Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
[TBL] [Abstract][Full Text] [Related]
14. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].
Netti GS; Ranieri E
G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016
[TBL] [Abstract][Full Text] [Related]
15. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
Stahl RA; Reinhard L; Hoxha E
Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
[No Abstract] [Full Text] [Related]
16. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.
Schlumberger W; Hornig N; Lange S; Probst C; Komorowski L; Fechner K; Dähnrich C; Stöcker W
Autoimmun Rev; 2014 Feb; 13(2):108-13. PubMed ID: 24075959
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach.
Glassock RJ
Clin J Am Soc Nephrol; 2014 Aug; 9(8):1341-3. PubMed ID: 25035274
[No Abstract] [Full Text] [Related]
19. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.
Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599
[TBL] [Abstract][Full Text] [Related]
20. Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.
Mahmud M; Pinnschmidt HO; Reinhard L; Harendza S; Wiech T; Stahl RAK; Hoxha E
PLoS One; 2019; 14(9):e0221293. PubMed ID: 31498806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]